Материал: Клинический протокол. ВРТ и искусственная инсеминация

into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol [Internet]. 2011;26(8):1083–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21692040

224.Lousse J-C, Van Langendonckt A, Defrere S, Ramos RG, Colette S, Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) [Internet]. 2012;4:23–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22201853

225.Duffy JMN, Arambage K, Correa FJS, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane database Syst Rev. 2014;(4):CD011031.

226.Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A, et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction [Internet]. 2009;137(4):727–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19129371

227.Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane database Syst Rev. 2004;(3):CD003678.

228.Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010 Oct;94(5):1609–15.

229.Zikopoulos K, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand [Internet]. 2004;83(7):651–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15225190

230.Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril [Internet]. 2002;78(4):757–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372452

231.Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane database Syst Rev

232.Gong F, Tang Y, Zhang H, Lu G. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban [Internet]. 2009;34(3):185–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19349670

233.van der Houwen LEE, Mijatovic V, Leemhuis E, Schats R, Heymans MW, Lambalk CB, et al. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation. Reprod Biomed Online [Internet]. 2014;28(1):39–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24262434

234.Giudice LC, Evers LH, Healy DL, editors. Endometriosis: science and practice. London: Wiley-Blackwell; 2012. 600 p.

235.Смольникова ВЮС. Изучение особенностей действия агонистов гонадотропинрилизинг гормона - депо-декапептила и нафарелина в программе экстракорпорального оплодотворения и переноса эмбрионов в полость матки. Москва; 1995. 24 p.

236.Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropinreleasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril [Internet]. 2002;78(4):699–704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372443

237.Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod [Internet]. 2005;20(10):2698–704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15980014

160

238.Leung AS, Dahan MH. The benefits of other treatments than in vitro fertilization to aid conception in minimal and mild endometriosis. Minerva Ginecol [Internet]. 2016;68(6):675– 86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27077394

239.Boujenah J, Santulli P, Mathieu-d’Argent E, Decanter C, Chauffour C, Poncelet P. [First line management without IVF of infertility related to endometriosis: Result of medical therapy? Results of ovarian superovulation? Results of intrauterine insemination? CNGOF-HAS Endometriosis Guidelines]. Gynecol Obstet Fertil Senol [Internet]. 2018;46(3):331–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29551300

240.Geisler ME, Ledwidge M, Bermingham M, McAuliffe M, McMenamin MB, Waterstone JJ. Intrauterine insemination-No more Mr. N.I.C.E. guy? Eur J Obstet Gynecol Reprod Biol [Internet]. 2017;210:342–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28122315

241.Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophinreleasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane database Syst Rev. 2015;(11):CD006919.

242.Bastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS J Soc Laparoendosc Surg [Internet]. 18(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/25392665

243.Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection

244.Kitajima M, Khan KN, Harada A, Taniguchi K, Inoue T, Kaneuchi M, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed) [Internet]. 2018;10:92–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930606

245.Yanushpolsky EH, Best CL, Jackson K V, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet [Internet]. 1998;15(4):193–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9565848

246.Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010 May;93(7):2431–2.

247.Brosens I. Endometriosis and the outcome of in vitro fertilization. Fertil Steril [Internet]. 2004;81(5):1198–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136075

248.Geber S, Ferreira DP, Spyer Prates LFV, Sales L, Sampaio M. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed

249.Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014 Oct;29(10):2190–8.

250.Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab [Internet]. 2012;97(9):3146–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22723324

251.Garcia-Velasco JA, Mahutte NG, Corona J, Zúñiga V, Gilés J, Arici A, et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril [Internet]. 2004;81(5):1194–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136074

252.Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G. IVF-ICSI

161

outcome in women operated on for bilateral endometriomas. Hum Reprod [Internet]. 2008;23(7):1526–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18441346

253.Ruiz Anguas J, Carballo Mondragón E, Anta Jaen E, Durán Monterrosas L, Kably Ambe A.

[Clinical implication and frequency of the incidental finding of endometriosis during oocyte retrieval]. Ginecol Obstet Mex [Internet]. 2007;75(3):121–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17547085

254.Cirpan T, Akercan F, Tavmergen Goker EN, Ozyurek E, Levi R, Tavmergen E. Laparoscopic resection or sonography-guided vaginal aspiration of endometriomas prior to ICSI-ET does not worsen treatment outcomes. Clin Exp Obstet Gynecol [Internet]. 2007;34(4):215–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18225681

255.Demirol A, Guven S, Baykal C, Gurgan T. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reprod Biomed Online [Internet]. 2006;12(5):639–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16790114

256.Yu H-T, Huang H-Y, Tseng H-J, Wang C-J, Lee C-L, Soong Y-K. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy. Biomed J [Internet]. 2017;40(5):295–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29179885

257.Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 21(6):809– 25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26168799

258.Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol [Internet]. 2017;209:81–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26968428

259.Jadoul P, Kitajima M, Donnez O, Squifflet J, Donnez J. Surgical treatment of ovarian endometriomas: state of the art? Fertil Steril [Internet]. 2012;98(3):556–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22763094

260.Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril [Internet]. 2017;108(3):483--490.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28865548

261.Mavrelos D, Holland TK, O’Donovan O, Khalil M, Ploumpidis G, Jurkovic D, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod Biomed Online

262.Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand [Internet]. 2017;96(6):715–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28556124

263.Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964–77.

264.Soave I, Wenger J-M, Pluchino N, Marci R. Treatment options and reproductive outcome for adenomyosis-associated infertility. Curr Med Res Opin [Internet]. 2018;34(5):839–49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29046066

265.Назаренко ТА. Стимуляция функции яичников. М.: МЕДпресс-информ; 2015. 288 p.

266.Wang B, Kong N, Liu J-Y, Zhang N-Y, Zhu Y-C, Zhou J-J. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy]. Zhonghua Nan Ke Xue [Internet]. 2017;23(12):1099–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29738181

162

267.Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis. J Hum Reprod Sci [Internet]. 9(2):70–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27382230

268.Youssef MA-F, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril [Internet]. 2018;109(2):289–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29317127

269.Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril [Internet]. 2015;104(5):1145. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26297646

270.Fan W, Li S, Chen Q, Huang Z, Ma Q, Wang Y. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol [Internet]. 2013;29(4):278–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347045

271.Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol [Internet]. 2014;12:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24555766

272.Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112–8.

273.Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with

compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol [Internet]. 2012;10:114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23249758

274.Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril [Internet]. 2018;109(6):993–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29935660

275.Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27(12):3481–6.

276.Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod [Internet]. 2013;28(11):2981–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23887073

277.Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, et al. Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. Front Endocrinol (Lausanne) [Internet]. 2018;9:317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29963011

278.Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of “Low prognosis patients in Assisted Reproductive Technology” and its proposed marker of

successful outcome. F1000Research [Internet]. 2016;5:2911. Available from:

163

http://www.ncbi.nlm.nih.gov/pubmed/28232864

279.Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. 2016;105(6):1452–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26921622

280.Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online [Internet]. 2012;24(4):424–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22386762

281.Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013 Jul;100(1):100–7.e1.

282.Galliano D, Bellver J, Díaz-García C, Simón C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update [Internet]. 21(1):13–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25155826

283.Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ [Internet]. 2000;320(7230):279–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10650023

284.Guida M, Pellicano M, Zullo F, Acunzo G, Lavitola G, Palomba S, et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod [Internet]. 2003;18(4):840–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12660281

285.Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril [Internet]. 2003;79(2):418–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12568856

286.AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol [Internet]. 2012;19(2):152–71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1553465011011897

287.Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun J-L, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol

288.Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol [Internet]. 2008;198(4):357–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18395031

289.Коган ИЮ, Беженарь ВФ, Долинский АК, Чмаро МГ. Эффективность вспомогательных методов репродукции у больных с миомой матки. Журнал акушерства и женских болезней. 2012;(4):113–8.

290.Seki H, Takizawa Y, Sodemoto T. Epidural analgesia for painful myomas refractory to medical therapy during pregnancy. Int J Gynaecol Obstet [Internet]. 2003;83(3):303–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14643043

291.Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol [Internet]. 2012;120(1):37–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678036

292.Тапильскя НИ, Карпеев СА, Гайдуков СН. Обоснование эффективности антибактериальной терапии в лечении хронической воспалительной болезни матки.

164